Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Pharmabiz
1h
China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD
China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...
15h
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grammy-winning singer dies
Helene death toll rises
Actor John Ashton dies
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
Rescue mission launched
Congestion fee bid denied
121st loss of the season
ISR airstrike kills Qaouk
'SNL' launches 50th season
Chief adviser subpoenaed
Malibu coast earthquake
Earth's orbit new asteroid
NC small plane crash
Ukrainian drones shot down
Steward CEO to step down
Condemns Israeli strikes
Ga. chemical plant fire
Temporary outage fixed
‘Wild Robot' tops box office
Faces fine to end Brazil ban
37 militants killed in Syria
Firefighters injured in crash
US wins Presidents Cup
Newsom vetoes AI safety bill
Trump's Erie rally
Blocks songs from artists
Defensive Player of the Year
AL sued over purging voters
Related topics
Regeneron
Sanofi
China
COPD
United States
Feedback